跳至主要内容
临床试验/TCTR20220712004
TCTR20220712004尚未招募4 期

The efficacy of oral etoricoxib in pain control during colposcopy-directed cervical biopsy: A randomized control trial

/A0 个研究点目标入组 110 人开始时间: 2022年7月12日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
Female

入选标准

  • abnormal cervical screening result that indication for colposcopy according to ASCCP2019
  • 7.HPV16/18 infection

排除标准

  • 1.NSAIDs allergy
  • 2.pregnancy or breast feeding
  • 3.history of pain killer 24 hours prior to colposcopy
  • 4.contraindication for etoricoxib as below
  • gastric ulcer or upper gastrointestinal bleeding
  • severe hepatic disease (serum albumin <25ng/l)
  • severe renal disease (CrCl <30 ml/min)
  • inflammatory bowel disease
  • heart failure
  • blood pressure more than 140/90 mmHg
  • coronary artery disease, peripheral arterial disease
  • history of thrombolytic drug, oral contraceptive pill

研究者

发起方
/A

相似试验